Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.22.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Consolidated Statements of Operations    
Revenues, net $ 1,273,712 $ 1,193,430
Cost of revenues 320,454 269,632
Gross Profit 953,258 923,798
Operating expenses    
Sales and marketing 1,920,749 1,025,404
Research and development 998,516 1,544,918
General and administrative 2,806,584 4,508,748
Impairment of goodwill & intangible assets 5,200,608 7,182,053
Total operating expenses 10,926,457 14,261,123
Loss from operations (9,973,199) (13,337,325)
Interest expense, net 825,209 405,279
Other (income) expense, net (390,414) (122,147)
Total other expense (income) 434,795 283,132
Net loss and comprehensive loss $ (10,407,994) $ (13,620,457)
Loss per share - basic $ (1.78) $ (2.66)
Loss per share - diluted $ (1.78) $ (2.66)
Weighted average number of shares outstanding - basic 5,844,006 5,128,421
Weighted average number of shares outstanding - diluted 5,844,006 5,128,421